Clinical Trial Update: 68Ga-NOTA-RM26 PET/CT in Glioma Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating 68Ga-NOTA-RM26 PET/CT in glioma patients is ongoing, with recruitment currently active. The study is sponsored by Pek…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• 68Ga-NOTA-RM26 (NOTA-RM26)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Glioma | EARLY_Phase 1 | Status: RECRUITING